VIDA FLaSH Acquisitions
Status: Stalled
U=S+W/4
W=S@11.50
| IPO Proceeds, $M | $150.00M |
|---|---|
| IPO Date | * |
| CEO | Frank Litvack |
| Left Lead | Goldman Sachs |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Healthcare in the United States |
| IPO Geography | US/Canada |
| Target Company | TBD |
| Deal Announced | TBD |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
FLSH
FLSHU
FLSHW
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on VIDA FLaSH Acquisitions:
- Structure and cap table
- 6 directors & officers
- 4 filings and events
- 1 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Frank Litvack | 65 | Chief Executive Officer and Director |
| R. Scott Huennekens | 56 | Chairman |
| John Blake | 44 | Chief Financial Officer |
| Siddhartha Kadia | 51 | Director |
| Renee Gaeta | 39 | Director |
| Michal Geva | 48 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Goldman Sachs | BR | 15,000,000 | units |
| 15,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 4 filings.